BMGL
Get informed when a big investor buys or sells
+ FollowUndervalued by 143.8% based on the discounted cash flow analysis.
| Market cap | $11.08 Million |
|---|---|
| Enterprise Value | $11.80 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $0 |
| Beta | 0.19 |
| Outstanding Shares | - |
| P/E Ratio | 0 |
|---|---|
| PEG | - |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | 0.31 |
| Debt to Equity | 0.76 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Holdings and activity of institutional investors.
| Ownership % | 0.29%▼ 0.48% |
|---|---|
| Total Invested | $32,215▼ 54.10% |
| Investors Holding | 3▼ 5.00% |
No data
Basel Medical Group Ltd provides healthcare services. The company offers services in the areas of medical specialists, medical supplies and equipment, medical technology, and pharmaceuticals. The company was incorporated in 2023 and is based in Singapore.